关注
Chantal E. Hargreaves
Chantal E. Hargreaves
在 ndm.ox.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Fcγ receptors: genetic variation, function, and disease
CE Hargreaves, MJJ Rose‐Zerilli, LR Machado, C Iriyama, EJ Hollox, ...
Immunological reviews 268 (1), 6-24, 2015
1032015
Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease: an association study and meta-analysis
MJ Simmonds, FK Kavvoura, OJ Brand, PR Newby, LE Jackson, ...
The Journal of Clinical Endocrinology & Metabolism 99 (1), E127-E131, 2014
952014
Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves’ disease
CE Hargreaves, M Grasso, CS Hampe, A Stenkova, S Atkinson, ...
The Journal of Immunology 190 (11), 5373-5381, 2013
842013
The role of genomics in common variable immunodeficiency disorders
AK Kienzler, CE Hargreaves, SY Patel
Clinical & Experimental Immunology 188 (3), 326-332, 2017
822017
Upregulation of FcγRIIb on monocytes is necessary to promote the superagonist activity of TGN1412
K Hussain, CE Hargreaves, A Roghanian, RJ Oldham, HTC Chan, ...
Blood, The Journal of the American Society of Hematology 125 (1), 102-110, 2015
752015
Impact of human FcγR gene polymorphisms on IgG-triggered cytokine release: critical importance of cell assay format
K Hussain, CE Hargreaves, TF Rowley, JM Sopp, KV Latham, P Bhatta, ...
Frontiers in immunology 10, 390, 2019
222019
Evaluation of high-throughput genomic assays for the Fc gamma receptor locus
CE Hargreaves, C Iriyama, MJJ Rose-Zerilli, SQ Nagelkerke, K Hussain, ...
PLoS One 10 (11), e0142379, 2015
192015
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy
K Hussain, R Liu, RCG Smith, KTJ Müller, M Ghorbani, S Macari, ...
Journal of Experimental & Clinical Cancer Research 41 (1), 131, 2022
132022
Association of FcGRIIa with Graves’ disease: a potential role for dysregulated autoantibody clearance in disease onset/progression
K Yesmin, C Hargreaves, PR Newby, OJ Brand, JM Heward, JA Franklyn, ...
Clinical endocrinology 73 (1), 119-125, 2010
132010
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma
JC Strefford, M Nowicka, CE Hargreaves, C Burton, A Davies, ...
Blood advances 5 (15), 2935-2944, 2021
122021
A novel, heterozygous three base-pair deletion in CARD11 results in B cell expansion with NF-κB and T cell anergy disease
AM Shields, BM Bauman, CE Hargreaves, AJ Pollard, AL Snow, SY Patel
Journal of Clinical Immunology 40, 406-411, 2020
122020
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment
M Nowicka, LK Hilton, M Ashton-Key, CE Hargreaves, C Lee, R Foxall, ...
Blood advances 5 (15), 2945-2957, 2021
92021
Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants
CE Hargreaves, F Dhalla, AM Patel, ACG De Oteyza, E Bateman, J Miller, ...
Clinical Immunology 234, 108910, 2022
72022
Decreased ATM function causes delayed DNA repair and apoptosis in common variable immunodeficiency disorders
CE Hargreaves, S Salatino, SC Sasson, JEG Charlesworth, E Bateman, ...
Journal of Clinical Immunology 41 (6), 1315-1330, 2021
72021
Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first‐line immunochemotherapy
C Jamois, E Gibiansky, L Gibiansky, V Buchheit, D Sahin, G Cartron, ...
British Journal of Clinical Pharmacology 85 (7), 1495-1506, 2019
72019
Prognostic impact of germ-line FCGR2A (H131R), FCGR3A (F158V), and FCGR2B (I232T) single nucleotide polymorphisms in lymphoma patients treated with obinutuzumab or rituximab in …
JC Strefford, M Nowicka, C Hargreaves, C Iriyama, KV Latham, ...
Blood 132, 4109, 2018
42018
An analysis of the rise, use, evolution and value of Anglo-American commando and special forces formations, 1939-1945
AL Hargreaves
King's College London, 2008
22008
Correction: evaluation of high-throughput genomic assays for the Fc gamma receptor locus
CE Hargreaves, C Iriyama, MJJ Rose-Zerilli, SQ Nagelkerke, K Hussain, ...
Plos one 11 (3), e0145040, 2016
12016
FCGR2A-131H/H is under-represented amongst patients with primary immunodeficiencies
EWD Flewitt, JEG Charlesworth, SY Patel, CE Hargreaves
medRxiv, 2023.10. 12.23296440, 2023
2023
Abstract PO-26: Prognostic significance of Fc gamma receptor IIB expression in the response of previously untreated diffuse large B-cell lymphomas to anti-CD20 monoclonal …
LK Hilton, M Nowicka, M Ashton-Key, CE Hargreaves, C Lee, R Foxall, ...
Blood Cancer Discovery 1 (3_Supplement), PO-26-PO-26, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20